ClinicalTrials.Veeva

Menu

Stiffness Measurement of Liver Tumors and Visceral Parenchyma

C

China Medical University

Status

Unknown

Conditions

Hepatocellular Carcinoma

Treatments

Other: stiffness measurement using ARFI

Study type

Observational

Funder types

Other

Identifiers

NCT01343212
DMR100-IRB-055

Details and patient eligibility

About

The investigators are measuring hepatocellular carcinoma(HCC)stiffness using Acoustic Radiation Force Impulse (ARFI) technique to enhance the diagnostic accuracy for HCC stratifications and treatment efficacy.

Full description

Regression modelings as well as validity testings including cut-off identification will be acquired by performing both qualitative and quantitative measurements of HCC using reference diagnostic modalities e.g. pathology grading, dynamic CT scanning, etc.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

with HCC

Exclusion criteria

  • subjects with liver cancer other than HCC
  • subjects with treated HCC
  • post major abdominal surgery
  • contraindications to liver tumor biopsy
  • contraindications to local percutaneous treatment of liver tumors
  • ARFI measurement low quality

Trial design

50 participants in 1 patient group

newly diagnosed HCC
Description:
* Subjects with newly diagnosed untreated hepatocellular carcinoma (HCC) will be enrolled. * Subjects with the following conditions will be excluded: liver cancer other than HCC, treated HCC, post major abdominal surgery, contraindications to liver tumor biopsy, contraindications to local percutaneous treatment of liver tumors, low quality ARFI measurement
Treatment:
Other: stiffness measurement using ARFI

Trial contacts and locations

1

Loading...

Central trial contact

Sheng-Hung Chen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems